Clinical Trials Directory

Trials / Completed

CompletedNCT04088331

Artificial Urinary Sphincter Clinical Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
145 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

To evaluate the AMS 800 Artificial Urinary Sphincter (AUS) in men with primary stress urinary incontinence as measured by pad weight tests.

Detailed description

Study is designed to evaluate the performance of the AMS 800 Artificial Urinary Sphincter (AUS) in men with primary stress urinary incontinence as measured by pad weight tests.

Conditions

Interventions

TypeNameDescription
DEVICEAMS 800 Artificial Urinary SphincterThe AMS 800 Artificial Urinary Sphincter (AUS) is an implantable, fluid filled, solid silicone elastomer device used to treat stress urinary incontinence due to reduced urethral/bladder outlet resistance (intrinsic sphincter deficiency). It is designed to restore the natural process of urinary control. The device simulates normal sphincter function by opening and closing the urethra under the control of the patient.

Timeline

Start date
2019-10-14
Primary completion
2024-05-13
Completion
2024-05-13
First posted
2019-09-12
Last updated
2026-01-14
Results posted
2025-08-03

Locations

18 sites across 2 countries: United States, Australia

Source: ClinicalTrials.gov record NCT04088331. Inclusion in this directory is not an endorsement.

Artificial Urinary Sphincter Clinical Outcomes (NCT04088331) · Clinical Trials Directory